RECENT NEWS

A new narrative review published in the current issue of Journal of Patient Safety, titled ’Putting Patients at Risk: The Effect of Health Care Provider Burnout on Patient Care in the Operating Room’ reveals alarmingly high levels of burnout among healthcare workers in operating rooms (ORs) and warns of the serious implications for staff well-being, care quality and ultimately patient safety.

​The number of students taking up nursing degrees in England has risen for the first time since the post-pandemic surge in 2021.

The 14 hospital Trusts to be looked at as part of a rapid, independent, national investigation into maternity and neonatal services have been named by the Department of Health.

The Association of British HealthTech Industries (ABHI) will once again lead one of the largest national pavilions at WHX Dubai 2026, taking place from 9–12 February 2026 at the Dubai Exhibition Centre.

The CORE-MD (Coordinating Research and Evidence for high-risk Medical Devices) consortium is publishing new consensus recommendations in The Lancet Regional Health Europe , that set out scientifically robust methodologies for clinical investigations of high-risk medical devices.

New research reveals that delays in heart valve disease diagnosis are disproportionately affecting those living in the most deprived areas of the UK.

​FUJIFILM Healthcare Europe and IRCAD France have announced a significant collaboration dedicated to enhancing surgical education and research programmes.

Bodies representing senior cancer experts say funding bureaucracy means some patients in England struggle to access the latest, best cancer treatments that could save their lives.

Thousands of mums-to be in England living with type 1 diabetes are to receive a pregnancy-specific, ‘artificial pancreas’ from the NHS to protect mothers and babies’ health.

Private healthcare provider, HCA Healthcare UK, has announced that it has treated a metastatic lung cancer patient with tumour-infiltrating lymphocyte (TIL) therapy for the first time as part of a clinical trial at its research arm, Sarah Cannon Research Institute UK.

Every Trust in England will be ranked quarterly against clear, consistent standards - from urgent and emergency care to elective operations and mental health services.

NHS Scotland spinout Aurum Biosciences has been invited to speak at a flagship life sciences conference in the US, further fostering its growth ambitions.

The National Kidney Cancer Audit (NKCA) have released the second 'State of the Nation' report evaluating patterns of care and outcomes for people diagnosed with kidney cancer in England.

New figures show London Ambulance Service has achieved the fastest response times for many years as it relentlessly focuses on improving performance in the face of growing demand for services.

Pentland Medical, through its subsidiary Innovel Medical, is sponsoring the upcoming Society for Airway Management (SAM) Webinar. This webinar offers an opportunity to better understand unplanned extubation, a critical yet under-recognised patient safety issue.

As universities welcome students back for the new academic year, the Association for Perioperative Practice (AfPP) is reminding aspiring perioperative practitioners that student membership is completely free.

An NHS Scotland partner has urged a fresh focus on the drive to improve healthcare through greener thinking after the launch of a new national facility supporting the transition to a sustainable net zero economy.

In countries where assisted dying is legal, policymakers often underestimate the extra capacity needed in the health and care system to get the service up and running and the ongoing funding needed to deliver it. MPs and MSPs should heed the warnings from international evidence, or the UK faces assisted dying becoming yet another service people struggle to access. That’s according to a new report published by the Nuffield Trust.

MPs have described a pioneering one-stop diabetes screening service as the future of how diabetes care should be provided during a recent visit to the Northern General Hospital.

The Medicines and Healthcare products Regulatory Agency (MHRA) has approved gepotidacin (Blujepa), a new kind of oral antibiotic pill to treat uncomplicated urinary tract infections (UTIs) in females.